Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties, used in trials for treating Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 842 € | 4-6 weeks |
Description | Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties, used in trials for treating Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease. |
Targets&IC50 | D2:8.1(pKi), D3:8.6(pKi) |
Alias | SLV-308, DU-126891 |
Molecular Weight | 233.27 |
Formula | C12H15N3O2 |
Cas No. | 269718-84-5 |
Smiles | O=C1OC2=C(C=CC=C2N1)N3CCN(C)CC3 |
Relative Density. | 1.258 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 10 mM | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.